Viemed Healthcare, Inc.
VMD
Rangering i aksjer
#14984
Viemed Healthcare, Inc., through its subsidiaries, provides home medical... Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Aksjekurs
$9.46
Sist synkronisert: 2026-10-16
Markedsverdi
$360.31M
Endring (1 dag)
-2.97%
Endring (1 år)
23.34%
Land
US
Handel Viemed Healthcare, Inc. (VMD)
Kategori
Healthcare
Markedsverdi av Viemed Healthcare, Inc.(VMD)
Markedsverdi: $360.31M
Per October 2026 har Viemed Healthcare, Inc. en markedsverdi på $360.31M. Dette gjør Viemed Healthcare, Inc. til det 14984th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Viemed Healthcare, Inc. fra 2017 til 2026
VMD sammenlignet med topp 5 mest populære stocks
